Investors

Directors’ Dealings

Share dealings of the Board of Executive Directors and Supervisory Board

(Obligatory reportable and publishable directors’ dealings under Article 19(1) of the E.U. Market Abuse Regulation 596/2014 (MAR))

As legally stipulated by Article 19(1) MAR, all members of the Board of Executive Directors and the Supervisory Board as well as close family relatives are required to disclose the purchase or sale of financial instruments of BASF SE (for example, shares, bonds, options, forward contracts, swaps) to the German Federal Financial Supervisory Authority (Bundesanstalt für Finanzdienstleistungsaufsicht) and to the company if transactions within the calendar year exceed the threshold of €20,000. In 2023, a total of 11 purchases by members of the Board of Executive Directors and the Supervisory Board of BASF SE and members of their families subject to disclosure were reported as directors’ dealings, involving between 800 and 3,400 BASF shares or BASF ADRs (American Depositary Receipts). The price per share was between €45.52 and €48.76. The volume of the individual transactions was between €34,134.94 and €154,779.

Share ownership by members of the Board of Executive Directors and the Supervisory Board

No member of the Board of Executive Directors or the Supervisory Board owns shares in BASF SE and related options or other derivatives that account for 1% or more of the share capital. Furthermore, the total volume of BASF SE shares and related financial instruments held by all members of the Board of Executive Directors and the Supervisory Board accounts for less than 1% of the shares issued by the company.

Closed periods

30 calendar days before public disclosure of a quarterly statement on the first or third quarter, half-year financial report or annual report of BASF SE.

Next closed periods:

  • January 24, 2024 to February 23, 2024*
  • March 26, 2024 to April 25, 2024
  • June 26, 2024 to July 26, 2024
  • September 30, 2024 to October 30, 2024
  • January 29, 2025 to February 28, 2025

Managers’ transactions

Name Date and Place of Transaction Type of Transaction   Price per Item Total Amount/ Currency   Reason for Disclosure Requirement/ Position Description of Financial Instrument ISIN

Dr. Markus Kamieth

03/04/2024 Xetra

Purchase

€46.98

€999,666.13

Board Member

Shares of BASF SE

DE000BASF111

Dr. Dirk Elvermann

01/24/20242 Tradegate

Purchase

€43.72

€109,306.50

Board Member

Shares of BASF SE

DE000BASF111

Dr. Stephan Kothrade

01/22/20242 Tradegate

Purchase

€42.65

€264,430.00

Board Member

Shares of BASF SE

DE000BASF111

Dr. Melanie Maas-Brunner 12/29/2023 Xetra Purchase €48.76 €34,134.94 Board Member Shares of BASF SE DE000BASF111

Dr. Dirk Elvermann

07/14/20231 Tradegate

Purchase

€45.52

€154,779.00

Board Member

Shares of BASF SE

DE000BASF111

Dr. Kurt Bock 04/28/2023 Xetra Purchase €45.88 €124,966.77 Supervisory Board Member Shares of BASF SE DE000BASF111
Dame Alison Carnwath 04/28/2023 Xetra Purchase €45.88 €49,959.18 Supervisory Board Member Shares of BASF SE DE000BASF111
Prof. Dr. Thomas Carell 04/28/2023 Xetra Purchase €45.88 €49,959.18 Supervisory Board Member Shares of BASF SE DE000BASF111
Liming Chen 04/28/2023 Xetra Purchase €45.88 €49,959.18 Supervisory Board Member Shares of BASF SE DE000BASF111
Prof. Dr. Stefan Asenkersch­baumer 04/28/2023 Xetra Purchase €45.88 €37,480.86 Supervisory Board Member Shares of BASF SE DE000BASF111
Alessandra Genco 04/28/2023 Xetra Purchase €45.88 €37,480.86 Supervisory Board Member Shares of BASF SE DE000BASF111
Dr. Melanie Maas-Brunner 04/28/2023 Off-market Purchase €45.63 €36,500.00 Board Member Shares of BASF SE DE000BASF111

Dr. Melanie Maas-Brunner

03/02/2023 Xetra

Purchase

€47.79

€57,352.30

Board Member

Shares of BASF SE

DE000BASF111

Dr. Markus Kamieth

02/28/2023 Xetra

Purchase

€48.44

€145,314.90

Board Member

Shares of BASF SE

DE000BASF111

Michael Heinz

02/27/2023
Börse Stuttgart

Purchase

€48.49

€96,970.00

Board Member

Shares of BASF SE

DE000BASF111

1 As BASF SE disclosed the preliminary figures for Q2 2023 on July 12, 2023 via an ad-hoc release, the closed period for Q2 2023 already ended prematurely on this date. 

2 As BASF SE disclosed the preliminary figures for FY 2023 on January 19, 2024 via an ad-hoc release, the closed period for FY 2023/Q4 2023 already ended prematurely on this date. 

Last Update March 5, 2024